APOE and glioblastoma: In our study, however, we used human glioblastoma astrocytes with identical genetic material to specifically assess potential differences in the ability of CSF HDL-like to promote cellular cholesterol efflux, thereby minimizing any confounding effects from cellular APOE variations.